ONO Pharmaceutical Co. Ltd.

03/14/2019 | Press release | Distributed by Public on 03/13/2019 21:34

ONO and Novartis Pharma Receive a Supplemental Approval for Formulation with New Ingredient of Rivastach® Patch and Exelon® Patch for the Treatment of Alzheimer's Disease[...]